J Weng Selected Research

J Weng Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 01/2017 - 04/2000
4	Inflammation (Inflammations) 01/2018 - 08/2014
3	Neoplasms (Cancer) 04/2024 - 08/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016 - 06/2015
2	Hypoxia (Hypoxemia) 01/2016 - 08/2009
2	Insulin Resistance 01/2016 - 02/2012
2	Body Weight (Weight, Body) 10/2013 - 10/2013
2	Macular Degeneration (Age-Related Maculopathy) 07/2001 - 06/2000
2	Hemorrhagic Fever with Renal Syndrome (HFRS) 11/2000 - 10/2000
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2020
1	Poisoning 04/2018
1	Leukemia 01/2018
1	Nocardia Infections 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2016
1	Liver Diseases (Liver Disease) 02/2016
1	Necrosis 02/2016
1	Fibrosis (Cirrhosis) 02/2016
1	Albuminuria 01/2016
1	Diabetes Mellitus 06/2015
1	Hypertrophy 09/2014
1	Prostatic Neoplasms (Prostate Cancer) 08/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2013
1	Obesity 06/2013
1	Hypertension (High Blood Pressure) 06/2013
1	Glucose Intolerance 06/2013
1	Dyslipidemias (Dyslipidemia) 06/2013
1	Overweight 06/2013
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Osteoporosis 01/2007
1	Type 6 MODY 01/2006
1	Type 3 Maturity-Onset Diabetes of the Young 01/2006
1	Cataract (Cataracts) 05/2001
1	Atrophic Gastritis 03/2001
1	Atrophy 03/2001
1	Infections 10/2000
1	Blindness (Hysterical Blindness) 06/2000

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2012
3	Insulin (Novolin)FDA Link 01/2016 - 04/2000
2	Proteins (Proteins, Gene)FDA Link 06/2015 - 07/2001
2	Acarbose FDA LinkGeneric 10/2013 - 10/2013
2	Glycoside Hydrolase InhibitorsIBA 10/2013 - 10/2013
2	LipofuscinIBA 07/2001 - 06/2000
2	VaccinesIBA 11/2000 - 10/2000
1	Pantothenic Acid (Calcium Pantothenate)FDA Link 04/2018
1	MethomylIBA 04/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2018
1	AcidsIBA 04/2018
1	Vitamin E FDA LinkGeneric 04/2018
1	XylitolIBA 04/2018
1	Palmitic Acid (Hexadecanoic Acid)IBA 04/2018
1	3-phenylpropionic acidIBA 04/2018
1	stearic acid (magnesium stearate)FDA LinkGeneric 04/2018
1	RibitolIBA 04/2018
1	Proline (L-Proline)FDA Link 04/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	Biocompatible Materials (Biomaterials)IBA 01/2018
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2016
1	Interleukin-17 (Interleukin 17)IBA 02/2016
1	CytokinesIBA 02/2016
1	Interleukin-6 (Interleukin 6)IBA 02/2016
1	AntioxidantsIBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Protective AgentsIBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	LipopolysaccharidesIBA 06/2015
1	CurcuminIBA 06/2015
1	Exenatide (Byetta)FDA Link 01/2015
1	Pioglitazone (Actos)FDA Link 01/2015
1	LeptinIBA 09/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2014
1	probasinIBA 08/2014
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 08/2009
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2007
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2007
1	LuciferasesIBA 01/2007
1	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 01/2006
1	Carboxypeptidase H (Carboxypeptidase E)IBA 01/2006
1	AutoantibodiesIBA 01/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2001
1	Epidermal Growth Factor (EGF)IBA 03/2001
1	Retinaldehyde (Retinal)IBA 06/2000
1	Glycogen Synthase (Synthase I)IBA 04/2000
1	EnzymesIBA 04/2000
1	Messenger RNA (mRNA)IBA 04/2000

Therapy/Procedure

3	Therapeutics 01/2018 - 04/2012
1	Radiotherapy 04/2024
1	Limb Salvage 01/2020
1	Immunotherapy 01/2018
1	Ligation 02/2016
1	Glycemic Control 10/2013
1	Contraindications 11/2000